None of the 29 investors followed here reported a position in AZTA in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 3 | +$24.0K | Bought Mar 3, 26 | |
| Josh Gottheimer NJ05 | 1 | −$8.0K | Sold Mar 19, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Mar 3, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Apr 7, 26 (35d) | |
| Jan 15, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Feb 13, 26 (29d) | |
| Oct 9, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Nov 18, 25 (40d) | |
| Mar 19, 25 | Josh Gottheimer NJ05 | Joint | Sell | $1,001 - $15,000 | Apr 10, 25 (22d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Bello Erik J.Officer | Stock Award(Grant) at price 0.00 per share. | 4.6K | — |
| Sep 13, 2026 | Pirogova OlgaOfficer | Stock Award(Grant) at price 0.00 per share. | 15.3K | — |
| Sep 13, 2026 | Lin Lawrence YChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 30.5K | — |
| Sep 13, 2026 | Starr EphraimGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 15.3K | — |
| Sep 13, 2026 | Madaus Martin D Ph.D.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 36.7K | — |
| Sep 13, 2026 | Martin William E IiiOfficer | Stock Award(Grant) at price 0.00 per share. | 15.3K | — |
| Jul 30, 2026 | Starr EphraimGeneral Counsel | Purchase at price 24.17 per share. | 335 | $8.10K |
| May 17, 2026 | Cornog William L.Director | Purchase at price 16.38 per share. | 10K | $163.80K |
| Apr 27, 2026 | Martin William E IiiOfficer | Stock Award(Grant) at price 24.24 per share. | 17.8K | $431.23K |
| Feb 5, 2026 | Nova Tina SusanDirector | Stock Award(Grant) at price 27.85 per share. | 5.7K | $157.72K |
| Feb 4, 2026 | Koffey QuentinDirector | Stock Award(Grant) at price 0.00 per share. | 5.7K | — |
| Feb 4, 2026 | Doshi DipalDirector | Stock Award(Grant) at price 27.85 per share. | 5.7K | $157.72K |
| Feb 4, 2026 | Mclaughlin EricaDirector | Stock Award(Grant) at price 27.85 per share. | 5.7K | $157.72K |
| Feb 4, 2026 | Casal FrankDirector | Stock Award(Grant) at price 27.85 per share. | 7.2K | $201.72K |
| Nov 23, 2025 | Zhou GingerOfficer | Stock Award(Grant) at price 0.00 per share. | 13K | — |
| Nov 23, 2025 | Pirogova OlgaOfficer | Stock Award(Grant) at price 0.00 per share. | 16.3K | — |
| Nov 23, 2025 | Lin Lawrence YChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 36.7K | — |
| Nov 23, 2025 | Starr EphraimGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 34.2K | — |
| Nov 23, 2025 | Marotta JohnChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 122.3K | — |
| Nov 23, 2025 | Marotta JohnChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 118.2K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 16.9 | -30.6 | -21.7 | 16.3 | -6.9 | 11.5 | 10.2 | 16.1 | 6.9 | 9.6 | +15.0% | ||
| 2025 | 8.1 | -19.3 | -20.6 | -24.0 | 1.4 | 15.2 | 6.2 | -6.6 | -6.0 | 5.2 | 17.7 | -6.5 | −33.5% |
| 2024 | 0.1 | -0.1 | -7.5 | -13.0 | -3.7 | 4.2 | 18.4 | -20.5 | -2.2 | -15.2 | 12.5 | 8.2 | −23.2% |
| 2023 | -4.0 | -21.5 | 1.7 | -2.5 | -0.6 | 7.9 | 0.6 | 20.1 | -11.1 | -9.4 | 24.0 | 15.6 | +11.9% |
| 2022 | -18.2 | 3.8 | -5.3 | -9.6 | 2.2 | -5.9 | -5.3 | -22.8 | -18.7 | 3.6 | 35.6 | -3.3 | −43.5% |
| 2021 | 11.7 | 9.8 | -1.8 | 24.1 | 0.8 | -6.7 | -6.6 | -4.6 | 20.5 | 13.8 | -2.9 | -8.8 | +52.0% |
| 2020 | -9.2 | -9.4 | -11.6 | 26.2 | 3.8 | 10.7 | 23.1 | -5.2 | -10.4 | 1.0 | 56.3 | -7.0 | +61.7% |
| 2019 | 18.9 | 3.1 | -8.7 | 27.9 | -5.4 | 9.2 | 0.1 | -14.1 | 11.1 | 14.7 | 5.4 | -6.3 | +60.3% |
| 2018 | 17.0 | -4.3 | 1.4 | -8.1 | 31.4 | -0.2 | -6.3 | 28.9 | -11.1 | -11.4 | -2.2 | -13.8 | +9.8% |
| 2017 | 2.1 | 19.7 | 7.4 | 12.8 | 9.1 | -21.3 | 13.2 | 6.1 | 16.5 | 13.3 | -27.6 | -4.2 | +39.7% |
| 2016 | -10.8 | 2.3 | 6.7 | -9.0 | 16.1 | 2.2 | 11.7 | 0.6 | 7.9 | -4.3 | 25.1 | 4.7 | +59.8% |
| 2015 | 1.3 | -7.0 | -3.1 | -7.5 | 4.5 | 1.9 | -7.9 | -1.6 | 12.8 | -5.7 | 1.0 | -4.2 | −16.2% |
| 2014 | -3.2 | 2.2 | 5.4 | -6.4 | -5.1 | 10.9 | -5.5 | 11.4 | -7.3 | 17.3 | -5.0 | 8.9 | +21.5% |
| 2013 | 16.3 | 8.0 | 0.7 | -4.5 | 9.6 | -8.6 | 0.9 | -10.4 | 5.8 | 3.5 | 9.6 | -0.8 | +30.3% |
| 2012 | 4.4 | 11.8 | 2.8 | -4.6 | -20.3 | 0.7 | -1.9 | -13.5 | 0.4 | -10.3 | 6.8 | 4.5 | −21.6% |
| 2011 | 29.4 | 6.9 | 9.4 | -10.9 | -7.3 | -4.2 | -12.4 | -0.4 | -13.9 | 28.2 | -8.7 | 7.7 | +13.2% |
| 2010 | -2.8 | 3.6 | 2.1 | 10.2 | -14.4 | -7.1 | -1.3 | -11.3 | -0.9 | 1.3 | 6.5 | 25.3 | +5.7% |
| 2009 | -21.3 | -6.3 | 7.7 | 34.9 | -37.8 | 15.8 | 32.4 | 9.6 | 18.9 | -11.0 | 6.5 | 17.1 | +47.7% |
| 2008 | -7.0 | -18.0 | -3.6 | 6.6 | -1.6 | -18.8 | -5.6 | 23.0 | -13.0 | -18.1 | -43.6 | 50.5 | −56.0% |
| 2007 | -3.3 | 11.6 | 10.4 | 1.9 | 1.3 | 2.6 | -3.2 | -19.5 | 0.6 | -8.8 | 3.5 | -1.6 | −8.3% |
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Buy / hold / sell counts